Prolonged inflammatory disorders of the digestive tract (PIDDT) are persistent disturbances of the digestive system. There are many disease units that belong to them, but the two most common are Crohn's disease (ChLC) and ulcerative colitis (UC). Both are classified as autoimmune diseases, which means that the body starts attacking its own cells, leading to their damage and inflammation. In the therapeutic process, lifestyle changes play a significant role, including nourishment.
Distinctive pathological and locational variations in inflammatory bowel diseases
Inflammatory bowel diseases (IBD) exhibit substantial variability in terms of both the anatomical localization of inflammatory processes and the nature of morphological alterations observed. **Crohn’s disease (CD)** is distinguished by transmural inflammation that permeates all layers of the gastrointestinal wall—spanning the mucosa, submucosa, muscularis propria, and serosa. The pathological lesions manifest as granulomatous, frequently segmental infiltrates and may affect any segment of the digestive tract, from the oral cavity to the anal canal. In contrast, **ulcerative colitis (UC)** is confined solely to the colonic mucosa, characterized by continuous, diffuse inflammatory involvement with numerous superficial ulcerations. This condition is exclusively localized to the large intestine, encompassing the rectum, sigmoid colon, and remaining colonic segments. Epidemiologically, IBD demonstrates a higher diagnostic prevalence in developed nations, predominantly among Caucasian individuals aged 20–40 years. Notably elevated incidence rates are observed in Scandinavian regions—for instance, in the Faroe Islands, where the disease frequency reaches approximately 84 cases per 100,000 inhabitants, representing a rate up to five times higher than the European average.
You have started reading a PRO article
You can preview the first chapter. To read the complete article and unlock all content, upgrade to a PRO account.